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Opposing motors take the strain
M
olecular motors 
show an odd 
sense of team-
work during cargo transport, 
say Ally et al. In order to 
get somewhere, they have to 
pull in opposite directions.
Many types of cargo move through the cell along micro-
tubules, but rather than smoothly gliding to their fi  nal destinations, 
they stutter back and forth due to motor proteins that pull in opposite 
directions. These bi-directional movements may help cargo navigate 
through a crowded cytosol. Surprisingly, the opposing motors seem 
to rely on each other—if one motor is removed, its rival seizes up 
instead of victoriously hauling its cargo to the microtubule’s end.
To investigate how such pairs of motors might communicate, 
Ally et al. wondered whether any two opposite polarity motors 
could combine to transport peroxisomes. These organelles are 
paralyzed in the absence of the plus end–directed motor kinesin-1, 
even though dynein—the protein that would usually shunt them to 
microtubule minus ends—is still present. Peroxisome movement in 
both directions was restored when a different kinesin, Unc104, was 
artifi  cially targeted to the organelle, suggesting that dynein can pair 
up with any plus end–directed motor. Similarly, kinesin-1 can partner 
with minus end motors other than dynein, the researchers found.
Kinesins lacking motor activity couldn’t restore peroxisome 
movements, indicating that transport in one direction is required 
to activate transport in the other. The mechanical tension 
produced by one motor might activate its opposing partner, says 
author Shabeen Ally. Once running, however, the opposing motor 
activities must be carefully balanced: the slow kinesin Eg5 could 
replace kinesin-1 and activate dynein, but was powerless to resist 
the minus end motor’s faster movement, causing peroxisomes to 
incorrectly accumulate in the center of the cell.
Ally, S., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200908075.
IKK cuts both ways in Huntington’s disease
T
he kinase IKK phosphorylates the protein mutated in Hun-
tington’s disease to promote its removal and neuron sur-
vival, say Thompson et al. But IKK may be a double-edged 
sword that increases neurotoxicity in later stages of the disease.
Huntington’s disease is caused by an expanded polyglutamine 
repeat in the protein Huntingtin (Htt), which causes the protein to 
aggregate and damage neurons. Ubiquitination and SUMOylation 
of Htt’s N-terminal domain affect the protein’s stability and 
toxicity, but other post-translational modifi  cations in this region 
of the protein might be important as well.
Thompson et al. discovered that the infl  ammatory kinase IKK 
phosphorylates Htt, altering the complex pattern of SUMOylation, 
ubiquitination, and acetylation on neighboring lysine residues. The 
net result was to promote Htt’s degradation by both the proteasome 
and lysosomes. Lysosome-mediated degradation of Htt was 
blocked by knocking down the autophagy proteins LAMP-2A 
and Atg7. Compared to wild type, mutant Htt with an expanded 
polyglutamine stretch was degraded ineffi  ciently, but a version that 
mimicked IKK phosphorylation with negatively charged aspartate 
residues was still less toxic to neuronal slice cultures.
But there may be a darker side to IKK phosphorylation—it also 
targets Htt to the nucleus where, says senior author Joan Steffan, a 
particularly toxic fragment that enhances neurodegeneration may 
accumulate. IKK may thus be involved in both clearing Htt and 
in generating a more dangerous version of the protein. The latter 
pathway would predominate in older patients because proteasome 
and lysosome function declines with age. Therapies aimed at 
IKK might need to either enhance or block the kinase’s function, 
depending on the patient’s age and stage of disease.
Thompson, L.M., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200909067.
BBS proteins run an export business
A 
protein complex 
mutated in human 
disease removes 
excess signaling molecules 
to prevent them from dam-
aging cilia, say Lechtreck 
et al.
Defective cilia cause 
a range of diseases includ-
ing Bardet-Biedl syndrome 
(BBS), a rare, multi-tissue disorder linked to mutations in 12 
different proteins. Seven of these form a complex called the 
BBSome, but the function of this protein assembly in cilia and 
fl  agella is unclear. In worms, the complex glues together the 
intrafl  agellar transport (IFT) machinery that assembles and main-
tains cilia by hauling cargo back and forth along the organelle’s 
microtubules. But most mammalian cell types can still form 
cilia in the absence of BBS proteins, suggesting that the BBSome 
isn’t essential for IFT.
Lechtreck et al. turned to the green alga Chlamydomonas, and 
found that BBS proteins were only present on a subset of IFT particles 
in each of the alga’s two fl  agella. Strains lacking components of the 
BBSome showed normal rates of IFT and proper fl  agellar structure, 
but couldn’t steer away from bright light like wild-type cells could. 
Mutant fl  agella accumulated several signaling-related proteins, 
which the researchers think may disrupt the alga’s response to light.
The researchers speculate that a similar buildup of disruptive 
proteins causes cilia dysfunction in BBS patients; the BBSome 
may remove excess signaling proteins from fl  agella by linking 
them to a subset of IFT particles undergoing retrograde transport 
out of the cilia. Author Karl Lechtreck says that the next step 
is to fl  uorescently tag the signaling proteins and compare their 
movements to BBS and IFT proteins.
Lechtreck, K.-F., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200909183.
Peroxisomes are immotile in the 
absence of kinesin-1 (left), but a distinct 
motor, Unc104, restores normal back-
and-forth movement (right).
The BBSome (red) removes signaling 
proteins from ﬂ  agella by linking them 
to a subset of IFT particles (green).